HCFA Hints At Expanded PET Review, While Hill Seeks Hands-Off Approach
This article was originally published in The Gray Sheet
Executive Summary
The MCAC Diagnostic Imaging Panel's upcoming review of PET imaging for Alzheimer's diagnosis may be expanded in scope to a broad review of existing diagnostic imaging modalities, according to HCFA Coverage and Analysis Group Director Sean Tunis.
You may also be interested in...
AHRQ Alzheimer's Diagnosis Technology Assessment To Focus On PET
The Agency for Healthcare Research & Quality's technology assessment on Alzheimer's disease diagnosis should include a systematic review of positron emission tomography studies as well as literature citations for other imaging modalities, according to the Medicare Coverage Advisory Commission's executive committee.
AHRQ Alzheimer's Diagnosis Technology Assessment To Focus On PET
The Agency for Healthcare Research & Quality's technology assessment on Alzheimer's disease diagnosis should include a systematic review of positron emission tomography studies as well as literature citations for other imaging modalities, according to the Medicare Coverage Advisory Commission's executive committee.
MCAC Amendments Open Up Panel Process, Broaden Scope Of Reviews
Evidence report questions for each Medicare Coverage Advisory Committee panel meeting will be made public much earlier in the review process under guidelines updated by the MCAC Executive Committee at a Feb. 22 meeting in Baltimore.